Trials / Unknown
UnknownNCT06125444
Impact of Hyperuricemia on Psoriatic Arthritis
IImpact of Hyperuricemia on Psoriatic Arthritis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 242 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link between these two rheumatisms, which to date has not been established. There is currently no recommendation to treat hyperuricaemia without an episode of gout attack. We hypothesize that there is a link between hyperuricemia and severity of rheumatism. This would ultimately modify the therapeutic management of hyperuricemic patients followed for psoriatic arthritis.
Conditions
Timeline
- Start date
- 2020-08-24
- Primary completion
- 2023-12-01
- Completion
- 2023-12-31
- First posted
- 2023-11-09
- Last updated
- 2023-12-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06125444. Inclusion in this directory is not an endorsement.